GPC vs STRO
Genuine Parts Co (GPC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
GPC currently screens at market cap $17.60B and trailing P/E 20.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the GPC and STRO stock pages for the full models.
Not investment advice.